{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:34:38Z","timestamp":1790278478671,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373675"],"award-info":[{"award-number":["82373675"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010972"],"award-info":[{"award-number":["2024A1515010972"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Science and Technology Development Foundation of Shenzhen","award":["JCYJ20220818095818040"],"award-info":[{"award-number":["JCYJ20220818095818040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02903-5","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T09:19:56Z","timestamp":1756113596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Atherogenic index of plasma and its 5-year changes associated with type 2 diabetes risk: a 10-Year cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Liuding","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueru","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canjie","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"2903_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157: 107843.","journal-title":"Diabetes Res Clin Pract"},{"key":"2903_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1758-5996-5-36","volume":"5","author":"M Ozery-Flato","year":"2013","unstructured":"Ozery-Flato M, Parush N, El-Hay T, Visockien\u0117 \u017d, Ryli\u0161kyt\u0117 L, Badarien\u0117 J, et al. Predictive models for type 2 diabetes onset in middle-aged subjects with the metabolic syndrome. Diabetol Metab Syndr. 2013;5:36.","journal-title":"Diabetol Metab Syndr"},{"key":"2903_CR3","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","volume":"58","author":"B Verg\u00e8s","year":"2015","unstructured":"Verg\u00e8s B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58:886\u201399.","journal-title":"Diabetologia"},{"key":"2903_CR4","first-page":"152","volume":"46","author":"M Dobiasova","year":"2000","unstructured":"Dobiasova M, Frohlich J. The new atherogenic plasma index (AIP) reflects the ratio of triglycerides and HDL-cholesterol, size of lipoprotein particles and esterification rate of cholesterol: changes after lipanor treatment. Vnitr Lek. 2000;46:152\u20136.","journal-title":"Vnitr Lek"},{"key":"2903_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/00033197211012129","volume":"72","author":"K Zhou","year":"2021","unstructured":"Zhou K, Qin Z, Tian J, Cui K, Yan Y, Lyu S. The atherogenic index of plasma: a powerful and reliable predictor for coronary artery disease in patients with type 2 diabetes. Angiology. 2021;72:934\u201341.","journal-title":"Angiology"},{"issue":"1","key":"2903_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12933-024-02370-4","volume":"23","author":"F-F You","year":"2024","unstructured":"You F-F, Gao J, Gao Y-N, Li Z-H, Shen D, Zhong W-F, et al. Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population\u2013based cohort study. Cardiovasc Diabetol. 2024;23:276.","journal-title":"Cardiovasc Diabetol"},{"key":"2903_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00592-021-01801-y","volume":"59","author":"Q Yi","year":"2022","unstructured":"Yi Q, Ren Z, Bai G, Zhu S, Li S, Li C, et al. The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese. Acta Diabetol. 2022;59:269\u201379.","journal-title":"Acta Diabetol"},{"key":"2903_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-023-01740-8","volume":"22","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wen M. Sex-specific differences in the effect of the atherogenic index of plasma on prediabetes and diabetes in the NHANES 2011\u20132018 population. Cardiovasc Diabetol. 2023;22:19.","journal-title":"Cardiovasc Diabetol"},{"key":"2903_CR9","doi-asserted-by":"publisher","first-page":"1460280","DOI":"10.3389\/fendo.2024.1460280","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu J, Fu Q, Su R, Liu R, Wu S, Li K, et al. Association between nontraditional lipid parameters and the risk of type 2 diabetes and prediabetes in patients with nonalcoholic fatty liver disease: from the National health and nutrition examination survey 2017\u20132020. Front Endocrinol. 2024;15:1460280.","journal-title":"Front Endocrinol"},{"key":"2903_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12933-023-01886-5","volume":"22","author":"B Yin","year":"2023","unstructured":"Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22:157.","journal-title":"Cardiovasc Diabetol"},{"key":"2903_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12933-024-02330-y","volume":"23","author":"Y Sun","year":"2024","unstructured":"Sun Y, Li F, Zhou Y, Liu A, Lin X, Zou Z, et al. Nonlinear association between atherogenic index of plasma and type 2 diabetes mellitus in overweight and obesity patients: evidence from Chinese medical examination data. Cardiovasc Diabetol. 2024;23:226.","journal-title":"Cardiovasc Diabetol"},{"key":"2903_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12933-023-01934-0","volume":"22","author":"X Zheng","year":"2023","unstructured":"Zheng X, Zhang X, Han Y, Hu H, Cao C. Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults. Cardiovasc Diabetol. 2023;22:205.","journal-title":"Cardiovasc Diabetol"},{"key":"2903_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/ije\/dyaa204","volume":"50","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhao Y, Sun L, Xi Y, Zhang W, Lu J, et al. Cohort profile: the rural Chinese cohort study. Int J Epidemiol. 2021;50:723\u2013l724.","journal-title":"Int J Epidemiol"},{"key":"2903_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1s\u0306ov\u00e1","year":"2001","unstructured":"Dobi\u00e1s\u0306ov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34:583\u20138.","journal-title":"Clin Biochem"},{"key":"2903_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3158","volume":"35","author":"W Jia","year":"2019","unstructured":"Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35: e3158.","journal-title":"Diabetes Metab Res Rev"},{"key":"2903_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"Y-W Li","year":"2021","unstructured":"Li Y-W, Kao T-W, Chang P-K, Chen W-L, Wu L-W. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep. 2021;11:1\u20138.","journal-title":"Sci Rep"},{"key":"2903_CR17","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1186\/s12889-024-21140-1","volume":"24","author":"G Ma","year":"2024","unstructured":"Ma G, Xu B, Wang Z, Duan W, Chen X, Zhu L, et al. Non-linear association of sleep duration with osteoarthritis among U.S. middle-aged and older adults. BMC Public Health. 2024;24:3565.","journal-title":"BMC Public Health"},{"key":"2903_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12944-024-02003-5","volume":"23","author":"J Zhang","year":"2024","unstructured":"Zhang J, Liu C, Peng Y, Fang Q, Wei X, Zhang C, et al. Impact of baseline and trajectory of the atherogenic index of plasma on incident diabetic kidney disease and retinopathy in participants with type 2 diabetes: a longitudinal cohort study. Lipids Health Dis. 2024;23:11.","journal-title":"Lipids Health Dis"},{"key":"2903_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12933-023-01936-y","volume":"22","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen S, Tian X, Wang P, Xu Q, Xia X, et al. Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population. Cardiovasc Diabetol. 2023;22:210.","journal-title":"Cardiovasc Diabetol"},{"key":"2903_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12933-023-01878-5","volume":"22","author":"Y Lan","year":"2023","unstructured":"Lan Y, Wu D, Cai Z, Xu Y, Ding X, Wu W, et al. Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study. Cardiovasc Diabetol. 2023;22:181.","journal-title":"Cardiovasc Diabetol"},{"key":"2903_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12933-024-02449-y","volume":"23","author":"Y Zou","year":"2024","unstructured":"Zou Y, Lu S, Li D, Huang X, Wang C, Xie G, et al. Exposure of cumulative atherogenic index of plasma and the development of prediabetes in middle-aged and elderly individuals: evidence from the CHARLS cohort study. Cardiovasc Diabetol. 2024;23:355.","journal-title":"Cardiovasc Diabetol"},{"key":"2903_CR22","doi-asserted-by":"publisher","first-page":"e0116110","DOI":"10.1371\/journal.pone.0116110","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang L, Chen S, Deng A, Liu X, Liang Y, Shao X, et al. Association between lipid ratios and insulin resistance in a Chinese population. PLoS One. 2015;10:e0116110.","journal-title":"PLoS One"},{"key":"2903_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12944-024-02180-3","volume":"23","author":"B Zhou","year":"2024","unstructured":"Zhou B, Rayner AW, Gregg EW, Sheffer KE, Carrillo-Larco RM, Bennett JE, et al. Non-linear association of atherogenic index of plasma with bone mineral density a cross-sectional study. Lipids Health Dis. 2024;23:181.","journal-title":"Lipids Health Dis"},{"key":"2903_CR24","doi-asserted-by":"publisher","first-page":"50230","DOI":"10.1074\/jbc.M200958200","volume":"277","author":"C Yu","year":"2002","unstructured":"Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;277:50230\u20136.","journal-title":"J Biol Chem"},{"key":"2903_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00125-006-0590-z","volume":"50","author":"DR Laybutt","year":"2007","unstructured":"Laybutt DR, Preston AM, \u00c5kerfeldt MC, Kench JG, Busch AK, Biankin AV, et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia. 2007;50:752\u201363.","journal-title":"Diabetologia"},{"key":"2903_CR26","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","volume":"119","author":"BG Drew","year":"2009","unstructured":"Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, et al. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 2009;119:2103\u201311.","journal-title":"Circulation"},{"key":"2903_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.2784","volume":"15","author":"Q Huang","year":"2014","unstructured":"Huang Q, Liu Z, Wei M, Huang Q, Feng J, Liu Z, et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol. 2014;15:152\u201360.","journal-title":"Nat Immunol"},{"key":"2903_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/00033197211054242","volume":"73","author":"JS Nam","year":"2022","unstructured":"Nam JS, Kim MK, Park K, Choi A, Kang S, Ahn CW, et al. The plasma atherogenic index is an independent predictor of arterial stiffness in healthy Koreans. Angiology. 2022;73:514\u20139.","journal-title":"Angiology"},{"key":"2903_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111\u20139.","journal-title":"J Clin Invest"},{"issue":"5","key":"2903_CR30","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI43378","volume":"121","author":"WL Holland","year":"2011","unstructured":"Holland WL, Bikman BT, Wang L-P, Yuguang G, Sargent KM, Bulchand S, et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid\u2013induced ceramide biosynthesis in mice. J Clin Invest. 2011;121(5):1858\u201370.","journal-title":"J Clin Invest"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02903-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:47:49Z","timestamp":1757483269000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02903-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2903"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02903-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"349"}}